The findings recommended the lncRNA-PCAT-1 act as an oncogenic in NSCLC progression and may be applicable as a novel curative approach for lung cancer (Zhao et al., 2015[25]). This evidence concerns the gene PCAT1 and non-small cell lung carcinoma.